Fig. 6From: Transcriptional profiling and biomarker identification reveal tissue specific effects of expanded ataxin-3 in a spinocerebellar ataxia type 3 mouse modelSignificantly altered metabolites at 4, 12 and 16 months of age in the MJD84.2 mouse model. a Levels of the 3 most significantly altered metabolites over time. b Levels of 3 most significantly altered lipids over time. Listed profilomic ID can be found in (Additional file 9 and 11). Based on 4 wild-type vs 4 SCA3 mice. Depicted is mean log areas ±SD per time pointBack to article page